Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours

Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours

Abstract NTRK gene fusions are rare somatic mutations found across cancer types with promising targeted therapies emerging. Healthcare systems face significant challenges in integrating these treatments, with uncertainty in prevalence and optimal testing methods to identify eligible patients. We per...

Полное описание

Библиографические подробности
Главные авторы:	Sophie O’Haire, Fanny Franchini, Yoon-Jung Kang, Julia Steinberg, Karen Canfell, Jayesh Desai, Stephen Fox, Maarten IJzerman
Формат:	Статья
Язык:	English
Опубликовано:	Nature Portfolio 2023-03-01
Серии:	Scientific Reports
Online-ссылка:	https://doi.org/10.1038/s41598-023-31055-3

Схожие документы

A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours
по: Yoon-Jung Kang, и др.
Опубликовано: (2022-11-01)

Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma
по: Simon Strohmeier, и др.
Опубликовано: (2021-05-01)

NTRK fusion in Japanese colorectal adenocarcinomas
по: Yuya Yamashiro, и др.
Опубликовано: (2021-03-01)

NTRK1 fusion in glioblastoma multiforme.
по: Jinkuk Kim, и др.
Опубликовано: (2014-01-01)

<i>NTRK</i> Fusions in 1113 Solid Tumors in a Single Institution
по: Heejin Bang, и др.
Опубликовано: (2022-06-01)

Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors
по: Jeongwan Kang, и др.
Опубликовано: (2020-09-01)

Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors
по: Mariana Petaccia de Macedo, и др.
Опубликовано: (2023-09-01)

Correction: NTRK1 Fusion in Glioblastoma Multiforme
Опубликовано: (2014-01-01)

NTRK amplification occurs frequently in pan-TRK immunopositive dedifferentiated liposarcomas
по: Zoltán Lippai, и др.
Опубликовано: (2025-01-01)

Pre‐ and post‐treatment blood‐based genomic landscape of patients with ROS1 or NTRK fusion‐positive solid tumours treated with entrectinib
по: Rafal Dziadziuszko, и др.
Опубликовано: (2022-05-01)

Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
по: Chunwei Xu, и др.
Опубликовано: (2022-11-01)

Case report: Adult NTRK-rearranged spindle cell neoplasms with TPM3-NTRK1 fusion in the pelvic
по: Qiurui Cao, и др.
Опубликовано: (2024-01-01)

Implementing competing risks in discrete event simulation: the event-specific probabilities and distributions approach
по: Fanny Franchini, и др.
Опубликовано: (2023-10-01)

NTRK fusions in osteosarcoma are rare and non‐functional events
по: Baptiste Ameline, и др.
Опубликовано: (2020-04-01)

Molecular and clinicopathologic features of gliomas harboring NTRK fusions
по: Matthew Torre, и др.
Опубликовано: (2020-07-01)

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
по: C. B. Westphalen, и др.
Опубликовано: (2021-07-01)

Case Report: Identification of a novel NTRK3-AJUBA fusion co-existing with ETV6-NTRK3 fusion in papillary thyroid carcinoma
по: Qing-Xiang Yu, и др.
Опубликовано: (2023-04-01)

NTRK-rearranged spindle cell tumor with SPECC1L-NTRK3 fusion in the thoracic spine: a case report
по: Mi Zhou, и др.
Опубликовано: (2024-12-01)

NTRK Somatic Fusions and Tumor Agnostic Treatment in Pediatric Cancers
по: Emel Ünal, и др.
Опубликовано: (2022-11-01)

Dermoscopic Features of Spitz Tumor With LMNA-NTRK1 Fusion
по: Ben J. Friedman, и др.
Опубликовано: (2020-12-01)

Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population
по: Ruiying Zhao, и др.
Опубликовано: (2021-07-01)

NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors
по: Eric Eunshik Kim, и др.
Опубликовано: (2024-07-01)

Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
по: C. B. Westphalen, и др.
Опубликовано: (2021-09-01)

Genomic Features of Solid Tumor Patients Harboring ALK/ROS1/NTRK Gene Fusions
по: Yinghuan Dai, и др.
Опубликовано: (2022-06-01)

Critical domains for NACC2-NTRK2 fusion protein activation.
по: Wei Yang, и др.
Опубликовано: (2024-01-01)

NTRK Fusions in a Sarcomas Series: Pathology, Molecular and Clinical Aspects
по: Vasiliki Siozopoulou, и др.
Опубликовано: (2022-05-01)

<i>NTRK</i> Fusions in Sarcomas: Diagnostic Challenges and Clinical Aspects
по: Vasiliki Siozopoulou, и др.
Опубликовано: (2021-03-01)

NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma
по: Yuekun Wang, и др.
Опубликовано: (2020-11-01)

Case report: STRN3-NTRK3 fusion in uterine sarcoma with spleen metastasis: a new variant in the spectrum of NTRK-rearranged tumors
по: Piergiuseppe Colombo, и др.
Опубликовано: (2024-11-01)

Prevalence of neurotrophic tropomyosin receptor kinase (NTRK) fusion gene positivity in patients with solid tumors in Japan
по: Eiji Nakata, и др.
Опубликовано: (2024-06-01)

Tumor Mutation Burden Survey of AACR GENIE Database Revealed NTRK (NTRK+) and RET (RET+) Fusions Positive Colorectal Carcinoma (CRC) as Distinct Subsets
по: Zhaohui Liao Arter, и др.
Опубликовано: (2025-02-01)

A case of thyroid carcinoma with mucinous features harboring ETV6-NTRK3 fusion: Expanding the morphologic spectrum of NTRK-rearranged thyroid carcinoma
по: Khaled A. Murshed, и др.
Опубликовано: (2022-06-01)

Detection of <i>NTRK</i> Fusions and TRK Expression and Performance of pan-TRK Immunohistochemistry in Routine Diagnostics: Results from a Nationwide Community-Based Cohort
по: Bart Koopman, и др.
Опубликовано: (2022-03-01)

Use of Diagnostic Algorithms for *NTRK* Fusion-Positive Tumors in Pathology Institutes in Switzerland
по: Holger Moch, и др.
Опубликовано: (2021-03-01)

BPI-28592 as a novel second generation inhibitor for NTRK fusion tumors
по: Jin Sheng, и др.
Опубликовано: (2024-09-01)

Systematic population-based identification of NTRK and RET fusion-positive thyroid cancers
по: Markus Eszlinger, и др.
Опубликовано: (2023-01-01)

Recurrent EGFR alterations in NTRK3 fusion negative congenital mesoblastic nephroma
по: Li Lei, и др.
Опубликовано: (2020-08-01)

Use of Diagnostic Algorithms for NTRK Fusion-Positive Tumors in Pathology Institutes in Switzerland
по: Holger Moch, и др.
Опубликовано: (2021-03-01)

Entrectinib approval by EMA reinforces options for ROS1 and tumour agnostic NTRK targeted cancer therapies
по: Salvatore Siena, и др.
Опубликовано: (2020-10-01)

Secretory carcinoma of major and minor salivary glands with ETV6-NTRK3 gene fusion: overcoming misdiagnosis in the era of tumour-agnostic therapy with TRK inhibitors
по: Monika Durzyńska, и др.
Опубликовано: (2023-08-01)